FRIDAY, SEPTEMBER 30, 2016

Global center launches to develop products to stem infectious disease

GHVCI launches to solve medical needs of infectious disease | Courtesy of myvmc.org

Sanofi Pasteur, Sanofi’s vaccine division, recently announced that it has launched a Global Health Vaccine Center of Innovation (GHVCI) as part of its collaboration with the Infectious Disease Research Institute (IDRI), a nonprofit, global-health institute that specializes in creating new products for infectious diseases.

The new Seattle-based center is partially funded with a grant from the Bill & Melinda Gates Foundation. This agreement was proposed as a research and development alliance called a Vaccine Discovery Partnership.

"IDRI is a partner of choice as they are a world leader in the development and evaluation of adjuvant formulations, using a broad portfolio of adjuvants with different immune-stimulating properties," Jim Tartaglia, research and development vice president for new vaccine projects at Sanofi Pasteur, said. "The institute has a world-class staff and capabilities in immunology and (good manufacturing practice) production.”

The center is designed to create vaccine adjuvant and/or formulation platforms as well as a pipeline for vaccine candidates. The researchers at the center will find, evaluate and create these vaccines and platforms to address a variety of infectious diseases.

"There are a number of diseases that are of great global-health significance, where Sanofi Pasteur could significantly contribute," John Shiver, senior vice president  for research and development at Sanofi Pasteur, said. "However, commercial realities provide a challenge to investment. The establishment of this Global Health Vaccines Center of Innovation represents a new opportunity -- operating within the open innovation R&D model -- to provide antigens, adjuvanted formulations, funding and expertise to allow development of needed vaccines."

Organizations in this story

Sanofi Pasteur Discovery Drive Swiftwater, PA 18370

Get notified the next time we write about Sanofi Pasteur!